2021 American Association of Neurology*

Download All
April 17 – 22, 2021; Virtual Meeting
Review the latest epilepsy management data with Capsule Summaries and an expert-authored commentary covering key studies from AAN 2021.

Capsule Summaries

Analysis of seizure-free patients suggests dose of ASMs may be able to be reduced while receiving concomitant cenobamate, without compromising long-term efficacy.

Released: April 26, 2021

Through 144 weeks of CBD add-on treatment, ≥50% reduction in seizures seen across multiple seizure types and across nearly all 24-week windows.

Released: April 26, 2021
Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Greenwich Biosciences, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue